Join
Live feed
·
INSIDERFilingvia Quantisnow
Artiva Biotherapeutics Inc. logo

Large owner Venbio Global Strategic Fund Iii, L.P. bought $4,999,992 worth of shares (416,666 units at $12.00), converted options into 1,058,284 shares and acquired 461,687 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ARTV· Artiva Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARTV (Artiva Biotherapeutics Inc.) and more on Quantisnow.